Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyspepsia.

P Bytzer1, N J Talley

  • 1Department of Medicine M, Division of Gastroenterology, Glostrup University Hospital, DK-2600 Glostrup, Denmark.

Annals of Internal Medicine
|May 11, 2001
PubMed
Summary
This summary is machine-generated.

Dyspepsia, or upper abdominal pain, affects 25% of people annually. Clinical diagnosis is unreliable, necessitating further investigation for serious conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Anxiety and Depression on the Interplay Between Disorders of Gut-Brain Interaction and Eating Disorders.

Clinical and translational gastroenterology·2026
Same author

Evidence for Brain-To-Gut and Gut-To-Brain Pathways in Primary Care Patients With Disorders of Gut-Brain Interaction, Inflammatory Bowel Disease and Gastroesophageal Reflux Disease.

Neurogastroenterology and motility·2025
Same author

Diabetes distress and depression are independently associated with gastrointestinal symptoms in type 2 diabetes in Bangladesh.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

Neonatal immune challenge influences the microbiota and behaviour in a sexually dimorphic manner.

Brain, behavior, and immunity·2022
Same author

Call for emergency action to limit global temperature increases, restore biodiversity and protect health.

BMJ military health·2021
Same author

Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial.

Alimentary pharmacology & therapeutics·2021
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Clinical Medicine

Background:

  • Dyspepsia, characterized by upper abdominal pain, is highly prevalent.
  • Symptoms often overlap with irritable bowel syndrome and reflux disease, complicating diagnosis.
  • Clinical presentation alone is an unreliable indicator of underlying gastrointestinal pathology.

Purpose of the Study:

  • To evaluate diagnostic criteria for dyspepsia.
  • To identify reliable methods for distinguishing serious conditions from functional dyspepsia.
  • To assess the validity of subgroup classifications and outcome measures.

Main Methods:

  • Review of clinical diagnostic approaches for dyspepsia.
  • Analysis of age thresholds and alarm features for identifying high-risk patients.
  • Examination of symptom-based subgroups and outcome measurement tools.

Related Experiment Videos

Main Results:

  • Unaided clinical diagnosis of dyspepsia is unreliable.
  • Age thresholds (e.g., 45 years) and alarm features (weight loss, vomiting, bleeding) show some validity.
  • Subgroup classifications (ulcer-like, dysmotility-like) have questionable clinical significance due to symptom overlap.
  • Lack of validated outcome measures hinders clinical studies.

Conclusions:

  • Accurate diagnosis of dyspepsia requires more than symptom assessment.
  • Further investigation is crucial for patients with dyspepsia, especially those with alarm features.
  • Development of validated outcome measures is essential for future clinical research in dyspepsia.